NORMAN SHARPLESS

Profile

First Name

: NORMAN

Middle Name

:

Last Name

: SHARPLESS

Related Companies

Titles

Company Name

Related People

DIRECTOR

G-ZERO THERAPEUTICS, INC.

CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, CHRISTY SHAFFER, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, CLAY THORP, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG

DIRECTOR

G1 THERAPEUTICS, INC.

CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, CHRISTY SHAFFER, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, CLAY THORP, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG

DIRECTOR

NUCLEUS RADIOPHARMA, INC.

JUSTIN BUTLER, CHARLES CONROY, CHRIS MCDONALD, MANU NAIR, TYRELL RIVERS, MICHAEL ROSSI, MARY KATE WOLD

DIRECTOR

INCYCLIX BIO, LLC

FREDRIC N. ESHELMAN, PATRICK ROBERTS, SID SUBRAMONY

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2025-08-06

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2022-10-04

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2023-09-15

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-02-04

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-10-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-10-08

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2013-04-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2013-04-03

D

PHARMACEUTICALS

NO REVENUES

Equity

2012-08-27